[Altered intestinal P-glycoprotein expression levels affect pharmacodynamics under diabetic condition]

Area of Science:

• Pharmacology and Toxicology
• Diabetology
• Drug Metabolism

Background:

• P-glycoprotein (P-gp) is a key efflux pump influencing drug pharmacokinetics and pharmacodynamics.
• Previous studies indicated transient decreases in intestinal P-gp expression in streptozotocin (STZ)-induced type 1 diabetic mice.
• The impact of diabetes on P-gp function and its consequence on drug efficacy remains an area of investigation.

Purpose of the Study:

• To investigate the analgesic effects and pharmacokinetics of orally administered morphine in a type 1 diabetic mouse model.
• To elucidate the specific role of intestinal P-glycoprotein (P-gp) in modulating morphine's effects under diabetic conditions.

Main Methods:

• Type 1 diabetes was induced in male ddY mice using streptozotocin (STZ).
• Oral morphine analgesia was assessed via the tail-flick test.
• Serum and brain morphine concentrations were quantified using High-Performance Liquid Chromatography with Electrochemical Detection (HPLC-ECD).
• Intestinal P-gp expression levels were analyzed.
• The effects of aminoguanidine, an iNOS inhibitor, were evaluated.

Main Results:

• STZ-induced diabetes significantly decreased intestinal P-gp expression on day 9 post-administration.
• Concurrently, oral morphine analgesia and serum/brain morphine levels were significantly elevated in diabetic mice.
• Aminoguanidine treatment suppressed the decrease in P-gp expression and the increase in morphine's effects.
• Subcutaneous morphine administration showed no altered analgesic effect in STZ-treated mice.

Conclusions:

• Oral morphine analgesia is significantly influenced by intestinal P-glycoprotein (P-gp) expression levels.
• Reduced intestinal P-gp in type 1 diabetes may lead to increased oral morphine bioavailability and efficacy.
• These findings highlight a potential challenge in achieving stable pharmacological effects of morphine in diabetic patients due to altered P-gp function.